Our consultants have experience in every therapeutic division of the FDA, in many cases, have worked on multiple indications in each area. Whether for a new chemical entity or a generic program, our team understands the development and regulatory hurdles you will face in dealing with the FDA and the various divisions. Our team also has extensive experience working with the European and Canadian regulatory agencies for multiple therapeutic areas and indications.